Moderna, Inc. (MRNA) FY2024 Q3 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2024-09-30

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2024 Q3 Balance SheetBalance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.Current liabilities$2.20 BCurrent assets$9.67 BLiabilities$3.88 BAssets$15.80 BNon-current liabilities$1.68 BEquity$11.93 BNon-current assets$6.14 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsAccounts receivable, netPrepaid expenses and other current assetsInventoryProperty, plant and equipment, netInvestments, non-currentRight-of-use assets, operating leasesOther non-current assetsDeferred tax assetsAccrued liabilitiesDeferred revenueAccounts payableOther current liabilitiesIncome taxes payableOperating lease liabilities, non-currentFinancing lease liabilities, non-currentOther non-current liabilitiesDeferred revenue, non-currentRetained earningsAdditional paid-in capitalAccumulated other comprehensive income (loss)Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccrued liabilitiesAccrued liabilities$1.38 BCurrent liabilitiesCurrent liabilities$2.20 BDeferred revenueDeferred revenue$379.00 MAccounts payableAccounts payable$373.00 MCurrent assetsCurrent assets$9.67 BLiabilitiesLiabilities$3.88 BInvestmentsInvestments$5.22 BOther current liabilitiesOther current liabilities$69.00 MAssetsAssets$15.80 BIncome taxes payableIncome taxes payable$4.00 MCash and cash equivalentsCash and cash equivalents$1.64 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$679.00 MNon-current liabilitiesNon-current liabilities$1.68 BAccounts receivable, netAccounts receivable, net$1.56 BFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$625.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$823.00 MOther non-current liabilitiesOther non-current liabilities$276.00 MInventoryInventory$412.00 MDeferred revenue, non-currentDeferred revenue, non-current$95.00 MEquityEquity$11.93 BProperty, plant and equipment, netProperty, plant and equipment, net$2.38 BNon-current assetsNon-current assets$6.14 BInvestments, non-currentInvestments, non-current$2.34 BRetained earningsRetained earnings$11.17 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$784.00 MOther non-current assetsOther non-current assets$556.00 MDeferred tax assetsDeferred tax assets$81.00 MAdditional paid-in capitalAdditional paid-in capital$751.00 MAccumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)$11.00 M
Chart details

Moderna, Inc. (MRNA) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets
15,803,000,000 US dollars
Current assets
9,666,000,000 US dollars
Non-current assets
6,137,000,000 US dollars
Liabilities
3,876,000,000 US dollars
Current liabilities
2,201,000,000 US dollars
Non-current liabilities
1,675,000,000 US dollars
Equity
11,927,000,000 US dollars
Investments
5,223,000,000 US dollars
Cash and cash equivalents
1,644,000,000 US dollars
Accounts receivable, net
1,564,000,000 US dollars
Prepaid expenses and other current assets
823,000,000 US dollars
Inventory
412,000,000 US dollars
Property, plant and equipment, net
2,381,000,000 US dollars
Investments, non-current
2,335,000,000 US dollars
Right-of-use assets, operating leases
784,000,000 US dollars
Other non-current assets
556,000,000 US dollars
Deferred tax assets
81,000,000 US dollars
Accrued liabilities
1,376,000,000 US dollars
Deferred revenue
379,000,000 US dollars
Accounts payable
373,000,000 US dollars
Other current liabilities
69,000,000 US dollars
Income taxes payable
4,000,000 US dollars
Operating lease liabilities, non-current
679,000,000 US dollars
Financing lease liabilities, non-current
625,000,000 US dollars
Other non-current liabilities
276,000,000 US dollars
Deferred revenue, non-current
95,000,000 US dollars
Retained earnings
11,165,000,000 US dollars
Additional paid-in capital
751,000,000 US dollars
Accumulated other comprehensive income (loss)
11,000,000 US dollars
Preferred stock, par value $0.0001; 162 shares authorized as of September 30, 2024 and December 31, 2023; no shares issued or outstanding at September 30, 2024 and December 31, 2023
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of September 30, 2024 and December 31, 2023; 385 and 382 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2024 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!